6 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
emboli • Lung abscess ... • HIV: 2/3 pulmonary ... Treatment: Active ... Initiating Treatment ... Diagnosis #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
emboli • Lung abscess ... • HIV: 2/3 pulmonary ... Treatment: Active ... Initiating Treatment ... Diagnosis #Management #Treatment
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Tuberculosis - ... Guidelines #Tuberculosis ... #medications #pharmacology ... IDSA #Guidelines #Treatment
Shock - Diagnosis and Management Summary
 • Hypotension: SBP<90, SBP drop >40, MAP<65 (Normotension, HTN possible
• Establish IV/IO ... Access - 2-large ... Tamponade - Pulmonary ... #criticalcare #treatment
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
drugs for use in a treatment ... multidrug-resistant tuberculosis ... success. ... MultiDrugResistant #Tuberculosis ... antimicrobials #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... & Dry) is the treatment ... kidneys where excess ... & Dry” is the treatment ... icu #clinical #pharmacology